The aim is to investigate whether signaling molecule PACAP-38 induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
21
Study participants will be allocated to receive continuous intravenous infusion of 10 pmol/kg/min PACAP-38.
Study participants will be allocated to receive continuous intravenous infusion of 20 mL placebo (isotonic saline).
Danish Headache Center
Copenhagen, Denmark
RECRUITINGIncidence of Migraine-Like Headache
Difference in incidence of headache with migraine-like features (0 to 12 hours) between PACAP-38 and placebo.
Time frame: 12 Hours
Headache Intensity Scores
Difference in area under the curve (AUC) for headache intensity scores (0 to 12 hours) between PACAP-38 and placebo.
Time frame: 12 Hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.